ArticleThe Journal of clinical investigation1998

beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.

D J Hicklin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.